Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Filing Meeting Email, February 1, 2012 - Octaplas

From: Drabick, Christine
Sent: Wednesday, February 01, 2012 9:52 AM
To: Rana, Pratibha; Kirschbaum, Nancy
Cc: Holobaugh, Patricia
Subject: Filing Memo: STN 125416/0 Octapharma, OctaplasLG

This email serves to document that based on my initial review of the clinical data contained in submission BLA STN 125416/0 for Octapharma’s OctaplasLG, the Bioresearch Monitoring Branch finds this submission acceptable for filing.


Christine Drabick, HFM-664

Bioresearch Monitoring Branch

Division of Inspections and Surveillance

Office of Compliance and Biologics Quality

Page Last Updated: 09/24/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English